Rapid Analysis of Biotherapeutics Using Protein A Chromatography Coupled to Orbitrap Mass Spectrometry DOI Creative Commons
Craig Jakes,

Florian Füssl,

Izabela Zaborowska

et al.

Analytical Chemistry, Journal Year: 2021, Volume and Issue: 93(40), P. 13505 - 13512

Published: Sept. 29, 2021

Monoclonal antibodies (mAbs) and related products undergo a wide range of modifications, many which can often be directly associated to culture conditions during upstream processing. Ideally, such should monitored fine-tuned based on real-time or close information obtained by the assessment product quality attribute (PQA) profile biopharmaceutical produced, is fundamental idea process analytical technology. Therefore, methods that are simple, quick robust, but sufficiently powerful, allow for generation comprehensive picture PQA protein interest required. A major obstacle analysis proteins from cultures presence impurities as cell debris, host DNA, small-molecule compounds, usually requires series capture polishing steps using affinity ion-exchange chromatography before characterization attempted. In current study, we demonstrate direct coupling with native mass spectrometry (ProA-MS) development robust method used generate mAbs in little 5 min. The developed was applied several samples ranging complexity stability, simple more complex monoclonal antibodies, well cysteine-conjugated antibody–drug conjugate mimics. Moreover, demonstrated suitability amounts <1 μg, suggests applicability early-stage activities.

Language: Английский

Rapid and comprehensive monoclonal antibody Characterization using microfluidic CE-MS DOI Creative Commons
Li Cao,

Daniel Fabry,

Kevin Lan

et al.

Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2021, Volume and Issue: 204, P. 114251 - 114251

Published: July 7, 2021

Language: Английский

Citations

21

Perspectives on capillary electrophoresis DOI
Barry L. Karger

TrAC Trends in Analytical Chemistry, Journal Year: 2023, Volume and Issue: 167, P. 117215 - 117215

Published: Aug. 5, 2023

Language: Английский

Citations

8

Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures DOI
J.-G. Castel,

S. Delaux,

Oscar Hernandez‐Alba

et al.

Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2023, Volume and Issue: 236, P. 115696 - 115696

Published: Sept. 9, 2023

Language: Английский

Citations

8

Characterization and monitoring of charge variants of a recombinant monoclonal antibody using microfluidic capillary electrophoresis-mass spectrometry DOI
Qiang Sun, Liang Wang, Na Li

et al.

Analytical Biochemistry, Journal Year: 2021, Volume and Issue: 625, P. 114214 - 114214

Published: April 26, 2021

Language: Английский

Citations

19

Rapid Analysis of Biotherapeutics Using Protein A Chromatography Coupled to Orbitrap Mass Spectrometry DOI Creative Commons
Craig Jakes,

Florian Füssl,

Izabela Zaborowska

et al.

Analytical Chemistry, Journal Year: 2021, Volume and Issue: 93(40), P. 13505 - 13512

Published: Sept. 29, 2021

Monoclonal antibodies (mAbs) and related products undergo a wide range of modifications, many which can often be directly associated to culture conditions during upstream processing. Ideally, such should monitored fine-tuned based on real-time or close information obtained by the assessment product quality attribute (PQA) profile biopharmaceutical produced, is fundamental idea process analytical technology. Therefore, methods that are simple, quick robust, but sufficiently powerful, allow for generation comprehensive picture PQA protein interest required. A major obstacle analysis proteins from cultures presence impurities as cell debris, host DNA, small-molecule compounds, usually requires series capture polishing steps using affinity ion-exchange chromatography before characterization attempted. In current study, we demonstrate direct coupling with native mass spectrometry (ProA-MS) development robust method used generate mAbs in little 5 min. The developed was applied several samples ranging complexity stability, simple more complex monoclonal antibodies, well cysteine-conjugated antibody–drug conjugate mimics. Moreover, demonstrated suitability amounts <1 μg, suggests applicability early-stage activities.

Language: Английский

Citations

19